Contraception

Contraception features

• 

  Preventing unintended pregnancies in women living with HIV in resource-poor settings

  Women with HIV in low-resource settings have high unmet needs for contraception. This article reviews evidence and programming issues....

  From:  HIV & AIDS treatment in practice

• 

  Contraceptive choices for women with HIV

  Information for women with HIV often includes advice on pregnancy and conception, but information on contraception that takes into account the needs of positive women can be harder...

  From:  HIV treatment update

Contraception news from aidsmap

• Injectable hormonal contraceptive does not raise HIV risk, large trial finds

  A large trial has found no difference in the risk of acquiring HIV for women using three different types of long-acting, reversible contraception in sub-Saharan Africa. Findings from the ECHO study were published today in The Lancet and presented ...

  13 June 2019 | Keith Alcorn

• Unintended pregnancies and desire for children: reproductive health needs of women living with HIV

  The needs for safe conception services and a wider choice of contraception for women living with HIV in sub-Saharan Africa were highlighted last week at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam. Recent international and ...

  01 August 2018 | Carole Leach-Lemens

• Efavirenz may undermine effectiveness of the vaginal ring contraceptive

  The antiretroviral drug efavirenz significantly reduces the levels of both hormones in the vaginal ring contraceptive in women with HIV, Kimberly Scarsi of University of Nebraska Medical Center reported on Wednesday at the Conference on Retroviruses and Opportunistic Infections ...

  08 March 2018 | Keith Alcorn

• Study finds that women are much more vulnerable to HIV infection during pregnancy and in the months after giving birth

  A study presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2018) found that women in two prevention studies were nearly three times more likely to become infected with HIV while they were pregnant, and four times ...

  05 March 2018 | Gus Cairns

• Reproductive health of HIV-positive women in Switzerland being neglected, says study

  HIV-positive women in Switzerland are mainly relying on male condoms for contraception, investigators report in HIV Medicine. Two-thirds of reproductive age women reported using contraception, with three-quarters of these individuals putting their trust in male condoms. ...

  06 February 2018 | Michael Carter

• Withdrawing Depo-Provera contraceptives would result in more lives lost than HIV infections prevented

  Even if Depo-Provera and other contraceptive injections raise the risk of HIV infection, withdrawing them from use in African countries would greatly increase maternal mortality, a modelling study has shown. The loss of life due to pregnancy complications and unsafe ...

  11 January 2018 | Roger Pebody

• Most contraceptives not linked to HIV infection, but Depo-Provera may raise risk

  Birth control pills and some types of injectable and implanted contraceptives were not associated with an increased risk of HIV acquisition in an updated meta-analysis that included several recent studies, researchers reported in the 5 August online edition of ...

  17 August 2016 | Liz Highleyman

• What do women want from a vaginal microbicide ring?

  In order to maximise confidence in its effectiveness, a vaginal microbicide ring for women would ideally need to be flexible, translucent and not too slippery, a focus group of women has told researchers. Many also said they would ideally ...

  18 February 2016 | Gus Cairns

• Lessons learnt from the history of contraception are relevant for the implementation of PrEP

  Achieving a widespread and appropriate use of pre-exposure prophylaxis (PrEP) will take several years and will require considerable attention to the shape and quality of health services, according to researchers who have looked at the way in which contraceptive ...

  06 January 2016 | Roger Pebody

• Hormonal contraception safe for women with HIV and may have important health benefits

  HIV-positive women can safely use hormonal contraception, according to research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Hormonal implants and injectable contraceptives were associated with a reduced mortality risk, and use of injectables ...

  06 November 2015 | Michael Carter

More news

Contraception news selected from other sources

• Efavirenz and rifampicin together reduce levels of injectable contraception

  Women with HIV receiving depot medroxyprogesterone acetate (DMPA), with efavirenz (EFV)-based ART and rifampicin (RIF)-based TB treatment, had lower MPA plasma levels compared with women not receiving the two drugs.

  29 March 2019 | HIV i-Base

• Double-dose levonorgestrel implant does not overcome interaction with efavirenz

  Using two levonorgestrel (LNG) implants does not fully overcome the drug-drug interaction with efavirenz (EFV) – according to findings from a pharmacokinetic (PK) evaluation of double-dose LNG in Ugandan women receiving EFV-based ART.

  29 March 2019 | HIV i-Base

• ‘Gag rule’ threatens to restrict women’s access to a highly effective HIV therapy

  As we wait for more evidence about the safety of dolutegravir during pregnancy, the solution is simple: ensure that women living with HIV have access to contraception so they can benefit from this medication. But that has become an often-insurmountable problem due to the global gag rule.

  11 February 2019 | STAT

• Could your favourite birth control put you at risk of HIV?

  We could be just months away from knowing whether Depo-Provera use is linked to a higher risk of HIV infection in women.

  23 November 2018 | Bhekisisa

• Why the world may force women to choose: No birth control, no ARVs

  A new drug could save 25 000 women living with HIV but could it come at the cost of their babies lives?

  22 August 2018 | Bhekisisa

• New evidence shows far-reaching impact of expanded US “global gag rule”

  Researchers shared alarming evidence at the 22nd International AIDS Conference (AIDS 2018) today of negative impacts of the US Government’s “Mexico City Policy”, also known as the “global gag rule”.

  27 July 2018 | International AIDS Society

• AIDS 2018: The Story is Messy

  It's already clear that the story from Amsterdam is that ending epidemic levels of new HIV diagnoses depends on building services and societies that recognize individuals as wonderful, wild, weird, whole people, with more specificity, respect and rigor than ever before. It also depends on activism, nasty women and their male allies, everyone demanding change, refusing to play nice.

  26 July 2018 | AVAC

• A clue for how to reduce HIV transmission when using hormonal contraceptives

  We also used mice to show that increases in tissue permeability and HIV transmission caused by Depo-Provera were eliminated in mice treated with Depo-Provera and Premarin, a vaginal estrogen cream prescribed to menopausal women. This implies contraceptives releasing progestin and estrogen have the potential to avoid the increases in HIV susceptibility caused by Depo-Provera alone.

  22 March 2018 | The Conversation US

• Contraception, HIV and control over black women’s bodies

  The apartheid-era practices of injecting women with a controversial contraceptive called Depo-Provera without their consent, is persisting today, according to multiple reports from activists, health workers and women who use public health.

  12 February 2018 | Daily Maverick

• Guidelines for the sexual and reproductive health of people living with HIV - consultation open

  These BHIVA / BASHH / FSRH guidelines are an update to the 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection (PLWH). They are open for consultation to Friday 8 December 2017.

  13 October 2017 | BHIVA

More news